Tubulis

Tubulis

featured image of Revolutionary Munich Company Doses First Patient with Groundbreaking Cancer Treatment

Revolutionary Munich Company Doses First Patient with Groundbreaking Cancer Treatment

BIOT

📢 Tubulis from Munich doses first patient with its ADC candidate TUB-040 targeting NaPi2b antigen in ovarian and lung cancer. 🧪